Total Valuation
Eli Lilly & Co has a market cap or net worth of $25.05T. The enterprise value is $1.08T.
Market Cap$25.05T
Enterprise Value$1.08T
Share Statistics
Eli Lilly & Co has 941,357,060 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding941,357,060
Owned by Insiders9.91%
Owned by Institutions12.34%
Financial Efficiency
Eli Lilly & Co’s return on equity (ROE) is 0.78 and return on invested capital (ROIC) is 30.20%.
Return on Equity (ROE)0.78
Return on Assets (ROA)0.18
Return on Invested Capital (ROIC)30.20%
Return on Capital Employed (ROCE)0.38
Revenue Per Employee1.30M
Profits Per Employee412.80K
Employee Count50,000
Asset Turnover0.58
Inventory Turnover0.80
Valuation Ratios
The current PE Ratio of Eli Lilly & Co is 45.9. Eli Lilly & Co’s PEG ratio is 0.48.
PE Ratio45.9
PS Ratio14.81
PB Ratio36.37
Price to FCF107.56
Price to Operating Cash Flow41.26
PEG Ratio0.48
Income Statement
In the last 12 months, Eli Lilly & Co had revenue of 65.18B and earned 20.64B in profits. Earnings per share was 23.07.
Revenue65.18B
Gross Profit54.13B
Operating Income29.70B
Pretax Income25.73B
Net Income20.64B
EBITDA31.69B
Earnings Per Share (EPS)23.07
Cash Flow
In the last 12 months, operating cash flow was 30.64B and capital expenditures -10.98B, giving a free cash flow of 19.66B billion.
Operating Cash Flow30.64B
Free Cash Flow19.66B
Free Cash Flow per Share20.89
Dividends & Yields
Eli Lilly & Co pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.46
52-Week Price Change61.71%
50-Day Moving Average21.27K
200-Day Moving Average19.11K
Relative Strength Index (RSI)77.88
Average Volume (3m)673.00
Important Dates
Eli Lilly & Co upcoming earnings date is Feb 10, 2027, Before Open (Confirmed).
Last Earnings DateOct 29, 2026
Next Earnings DateFeb 10, 2027
Ex-Dividend Date―
Financial Position
Eli Lilly & Co as a current ratio of 1.58, with Debt / Equity ratio of 122.92%
Current Ratio1.58
Quick Ratio1.19
Debt to Market Cap0.04
Net Debt to EBITDA1.12
Interest Coverage Ratio37.34
Taxes
In the past 12 months, Eli Lilly & Co has paid 5.09B in taxes.
Income Tax5.09B
Effective Tax Rate0.20
Enterprise Valuation
Eli Lilly & Co EV to EBITDA ratio is 31.57, with an EV/FCF ratio of 111.50.
EV to Sales15.35
EV to EBITDA31.57
EV to Free Cash Flow111.50
EV to Operating Cash Flow59.50
Balance Sheet
Eli Lilly & Co has $4.88B in cash and marketable securities with $49.50B in debt, giving a net cash position of -$44.62B billion.
Cash & Marketable Securities$4.88B
Total Debt$49.50B
Net Cash-$44.62B
Net Cash Per Share-$47.40
Tangible Book Value Per Share$15.72
Margins
Gross margin is 83.63%, with operating margin of 45.56%, and net profit margin of 31.67%.
Gross Margin83.63%
Operating Margin45.56%
Pretax Margin39.48%
Net Profit Margin31.67%
EBITDA Margin48.62%
EBIT Margin45.56%
Analyst Forecast
The average price target for Eli Lilly & Co is $28,198.48, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$28,198.48
Price Target Upside42.00% Upside
Analyst ConsensusStrong Buy
Analyst Count24
Revenue Growth Forecast30.79%
EPS Growth Forecast35.85%